LITTLE ROCK, Ark.--(BUSINESS WIRE)--Kelyniam Global, Inc. (OTCBB: KLYG), an advanced Engineering and Rapid Prototyping Company proudly announces today that the Company has received a Contract to produce Cranial Implant Prototype Models.
Kelyniam Engineering Division has been working very closely with a major medical supplier to implement rapid prototyping technologies in the custom production of cranial implants. We have had to overcome a number of hurdles prior to the commercial release of the product. Now that the process has been tested and proven, our partners are looking to start selling these products as a better and safer alternative to the traditional implant methods.
Mr. John Mastoloni, Vice President/Sales and Marketing stated: “This represents a huge leap in health care. With the implementation of CAD/CAM and rapid prototyping, we are looking to produce a high tolerance, more comfortable and reduced recovery time implant than was possible with traditional techniques.”
Kelyniam Engineering Division presently has eight Stereolithography Machines that can be dedicated to this effort and a support staff available 7 days a week, 24 hours a day to reaffirm our commitment to this new contract.
Mr. Thomas Ziolkowski, Kelyniam Engineering Operations Manager added: “We recently expanded our production capabilities in anticipation of this new contract and are in the process of allocating more space and more machines towards this growth. We have invested a significant amount of capital resources in restructuring our manufacturing and quality control processes as a means to absorb the anticipated increase in production.”
All engineering development for this new technology is being performed at Kelyniam’s engineering and manufacturing facility in New Britain Connecticut.
More information about Kelyniam Global, Inc. can be found by following the links provided on our home page. (www.kelyniam.com)
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Kelyniam Global, Inc. intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes’’ “seeks,” “estimates,” or variations of such words are intended to identify such forward-looking statements. Additional uncertainties and risks are described in Kelyniam Global, Inc.’s most recently filed SEC documents, such as its most recent annual report on Form 10K. Copies of these filings are available through the SEC website at www.sec.gov. All forward-looking statements are based upon information available to Kelyniam Global, Inc. on the date hereof. Kelyniam Global, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Kelyniam Global, Inc.
Michelle LynRay, 1-800-280-8192
www.kelyniam.com
864.41 (9.32%)